
Dow Schofield Watts advises on Avacta PLC’s strategic divestment of its Diagnostics Division
Dow Schofield Watts advised on the sale of Coris Bioconcept SRL (“Coris”) by Avacta Group PLC (“Avacta” or the “Company”) to an Indian-listed company, 3B BlackBio Dx Ltd (“3B BlackBio”), which formally completed on 29 August 2025 following the satisfaction of all closing conditions.